Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +28 |
| Ticker | KLTO |
| Latest Price | 1.14 USD as of close on 03-Jul-2025 |
| 3 Month price range | 0.13 to 2.01 USD |
| Market Capitalisation | 17.65Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates comprise KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska. See More ... |
| Company URL | https://klothoneuro.com |
| See Darwins Full Analysis for Klotho Neurosciences Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Klotho Neurosciences Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +18 |
| Sentiment | News and Candle Patterns. | +3 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +7 |
There are 5 peers of Klotho Neurosciences Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Carisma Therapeutics Inc (CARM) | Biotechnology | +129.0 | +2 |
| Ligand Pharmaceuticals Inc (LGND) | Biotechnology | +10.4 | +18 |
| Protagonist Therapeutics Inc (PTGX) | Biotechnology | -0.9 | +24 |
| Vericel Corp (VCEL) | Biotechnology | -3.3 | +3 |
| Xencor Inc (XNCR) | Biotechnology | -7.5 | -28 |
To see complete information on Klotho Neurosciences Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |